What is mutual recognition procedure?

The mutual recognition procedure is a European authorisation procedures based on the principle of recognition of the assessment by the Reference Member State (RMS). The Co-ordination Group for Mutual recognition and Decentralised procedures (CMDh) has published several Guidance documents regarding MRP and DCP.

What is MRP Pharmaceutical?

MRP. Mutual Recognition Procedures. Procedure, Recognition, Product.

What is CMDh?

The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh), was set up in Directive 2004/27/ EC for the examination of any question relating to marketing authorisations of a medicinal product in two or more Member States in accordance with the mutual recognition procedure or the …

How does Decentralised procedure work?

How does the decentralised procedure work? An identical application for marketing authorisation is submitted simultaneously to the competent authorities of the Reference Member State and of the Concerned Member States.

What is MRP and DCP?

A Marketing Authorisation Holder ( MAH ) can use the Mutual Recognition Procedure ( MRP ) for the same authorisation more than once after completion of a first MRP or a Decentralised Procedure ( DCP ) for the recognition of a marketing authorisation by other Member States ( MS ).

What is MAA submission?

Marketing Authorisation Application (MAA) is an application submitted by a drug manufacturer seeking marketing authorisation, that is permission to bring a medicinal product (for example, a new medicine or generic medicine) to the market.

What is gmap in pharmacy?

The Food and Drug Administration (FDA) has two initiatives for lowering drug prices: Government Mediated Access Price (GMAP) and Maximum Drug Retail Price (MDRP). GMAP is a mediated action made by the FDA to convince drug companies to lower the prices of the their products.

What is EU MRP?

Market Authorization Holder (MAH) who already has authorization for a medicinal product in a member state of the European Union (EU) can choose Mutual Recognition Procedure (MRP) in order to procure authorization in multiple EU member states.

What is a Type 2 variation?

A major change to a marketing authorisation that may have a significant impact on the quality, safety or efficacy of a medicine, but does not involve a change to the active substance, its strength or the route of administration.

What is the difference between mutual recognition procedure and Decentralised procedure?

The decentralised procedure ( DCP ) is a European authorisation route resulting in a mutually recognised product ( MRP ). The difference between MRP and DCP is that a product must already be authorised in at least one Member State on a national basis in order for MRP to be used.

What is the difference between DCP and MRP?

The main difference between the MRP and DCP lies in the fact that the Concerned Member States (CMSs) in a DCP are involved at the onset of the procedure as opposed to waiting for approval before an application is made in the CMS.

What is mutual recognition procedure in EU?

mutual-recognition procedure, whereby a marketing authorisation granted in one Member State can be recognised in other EU countries; decentralised procedure, whereby a medicine that has not yet been authorised in the EU can be simultaneously authorised in several EU Member States.

What is RMS in Europe?

The European Medicines Agency (EMA) has launched the Referentials Management Service (RMS) to support regulatory activities throughout the European Union (EU). The RMS manages one of the four domains of substance, product, organisation and referential (SPOR) master data in pharmaceutical regulatory processes.

Is Maa same as NDA?

The application for marketing authorization is called New Drug Application (NDA) in the USA or Marketing Authorization Application (MAA) in the European Union. So, both NDA and MAA is application filed to obtain the marketing permission. Upon receiving the approval, medicine can be launched in market.

What is MAA document?

Sample 2. Based on 22 documents. 22. MAA means a marketing authorization application or equivalent application, and all amendments and supplements thereto, filed with the applicable Regulatory Authority in any country or jurisdiction.

What is gmap and Mdrp?

What is drug retail price list?

The prescription drug retail price list shall contain the retail price charged by the pharmacy for each listed drug’s most commonly prescribed dosage, in quantities of 30, 60 or 90 units, if applicable, and shall include the drug’s price per unit.

What is RMS and CMS in Europe?

The Member State that has already authorised the product is known as the Reference Member State ( RMS ). The RMS submits their evaluation of the product to other Member State/s, these are known as Concerned Member States ( CMS ). The CMS is asked to mutually recognise the MA of the RMS .

What is a Type 1 variation?

A minor change to a marketing authorisation that has a minimal or no impact on the quality, safety or efficacy of the medicine and does not require prior approval before implementation by the marketing authorisation holder.

How long does a type II variation take?

The majority of type II variation procedures following a 30-day timetable (e.g. urgent safety issues) will most commonly follow the monthly start timetable. This is because they are likely to require Commission Decision within two months from CHMP Opinion and discussion during the CHMP plenary meeting.

What is the mutual recognition procedure?

The mutual recognition procedure is a European authorisation procedures based on the principle of recognition of the assessment by the Reference Member State (RMS). The Co-ordination Group for Mutual recognition and Decentralised procedures (CMDh) has published several Guidance documents regarding MRP and DCP.

What is the co-ordination Group for mutual recognition and decentralised procedures?

The Co-ordination Group for Mutual recognition and Decentralised procedures (CMDh) has published several Guidance documents regarding MRP and DCP. In the case of the Mutual recognition procedure (MRP), the RMS has already issued a marketing authorisation.

How long does it take to validate a mutual recognition application?

All incoming mutual recognition applications should be registered and validated within 14 days by CMS, in accordance with the CMD(h) document Procedure for Automatic Validation of MR Procedures for New Applications.

Can MEB act as reference member state for mutual recognition?

A request to the MEB to act as Reference Member State in the Mutual recognition procedure should preferably be announced upon submitting the national application.